Lipid risk factors and the regression of atherosclerosis

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Angiographically monitored clinical trials of antilipidemic therapy have demonstrated that the progression of atherosclerosis may be slowed or even reversed. The clinical benefit observed in these trials strengthens the rationale for aggressive therapy in patients with known atherosclerotic disease. Additionally, these trials have provided further insight on the basis of clinical events and the risk factors associated with progression.

Original languageEnglish (US)
JournalThe American Journal of Cardiology
Issue number1-2 SUPPL. 1
StatePublished - Jul 13 1995

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Lipid risk factors and the regression of atherosclerosis'. Together they form a unique fingerprint.

Cite this